Vitamin D3 Enriches Ceramide Content in Exosomes Released by Embryonic Hippocampal Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
27 Aug 2021
Historique:
received: 19 07 2021
revised: 18 08 2021
accepted: 24 08 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 21 10 2021
Statut: epublish

Résumé

The release of exosomes can lead to cell-cell communication. Nutrients such as vitamin D3 and sphingolipids have important roles in many cellular functions, including proliferation, differentiation, senescence, and cancer. However, the specific composition of sphingolipids in exosomes and their changes induced by vitamin D3 treatment have not been elucidated. Here, we initially observed neutral sphingomyelinase and vitamin D receptors in exosomes released from HN9.10 embryonic hippocampal cells. Using ultrafast liquid chromatography tandem mass spectrometry, we showed that exosomes are rich in sphingomyelin species compared to whole cells. To interrogate the possible functions of vitamin D3, we established the optimal conditions of cell treatment and we analyzed exosome composition. Vitamin D3 was identified as responsible for the vitamin D receptor loss, for the increase in neutral sphingomyelinase content and sphingomyelin changes. As a consequence, the generation of ceramide upon vitamin D3 treatment was evident. Incubation of the cells with neutral sphingomyelinase, or the same concentration of ceramide produced in exosomes was necessary and sufficient to stimulate embryonic hippocampal cell differentiation, as vitamin D3. This is the first time that exosome ceramide is interrogated for mediate the effect of vitamin D3 in inducing cell differentiation.

Identifiants

pubmed: 34502192
pii: ijms22179287
doi: 10.3390/ijms22179287
pmc: PMC8430480
pii:
doi:

Substances chimiques

Ceramides 0
Receptors, Calcitriol 0
VDR protein, human 0
Vitamins 0
Cholecalciferol 1C6V77QF41
Sphingomyelin Phosphodiesterase EC 3.1.4.12

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Interreg Italia-Slovenia programme 2014-2020 Project "IMMUNOCLUSTER"
ID : CUP G24I19002700006

Références

Front Cell Neurosci. 2018 Feb 07;12:31
pubmed: 29467625
Eur Respir J. 2019 Oct 24;54(4):
pubmed: 31439681
J Cell Sci. 2015 Mar 15;128(6):1065-70
pubmed: 25774051
Curr Pharm Des. 2020;26(21):2475-2491
pubmed: 32175837
ISRN Nephrol. 2013 Sep 04;2013:898125
pubmed: 24967240
Hippocampus. 2010 Jun;20(6):696-705
pubmed: 19603526
Int J Mol Sci. 2019 Sep 06;20(18):
pubmed: 31489901
Mol Biol Cell. 2011 Sep;22(17):3022-31
pubmed: 21737687
Allergy. 2018 Jan;73(1):37-49
pubmed: 28675776
Br J Pharmacol. 2017 Apr;174(8):605-627
pubmed: 28127747
Cells. 2020 Nov 08;9(11):
pubmed: 33171624
Curr Opin Cell Biol. 2009 Aug;21(4):575-81
pubmed: 19442504
J Allergy Clin Immunol. 2017 Apr;139(4):1186-1194
pubmed: 27566455
Biomark Med. 2013 Oct;7(5):769-78
pubmed: 24044569
Nutrients. 2020 Apr 02;12(4):
pubmed: 32252241
Neurosci Lett. 2015 Mar 4;589:83-7
pubmed: 25556686
J Lipid Res. 2008 May;49(5):1137-46
pubmed: 18281723
J Neurotrauma. 2000 Oct;17(10):891-8
pubmed: 11063055
Int J Mol Sci. 2019 Jul 25;20(15):
pubmed: 31349547
Cells. 2019 Apr 03;8(4):
pubmed: 30987213
J Steroid Biochem Mol Biol. 2019 Feb;186:130-135
pubmed: 30336275
Lipids Health Dis. 2016 Oct 19;15(1):183
pubmed: 27756324
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Trends Cell Biol. 2015 Jun;25(6):364-72
pubmed: 25683921
Leukemia. 2017 Apr;31(4):985-988
pubmed: 28008175
Methods Mol Biol. 2018;1697:153-171
pubmed: 28540559
Int J Mol Sci. 2021 Jan 23;22(3):
pubmed: 33498689
Mol Biol Cell. 2015 Jul 1;26(13):2418-25
pubmed: 26124436
Annu Rev Biochem. 2019 Jun 20;88:487-514
pubmed: 31220978
Anal Bioanal Chem. 2011 Aug;401(3):891-9
pubmed: 21698504

Auteurs

Carmela Conte (C)

Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.

Samuela Cataldi (S)

Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.

Cataldo Arcuri (C)

Department of Medicine and Surgery, University of Perugia, 06126 Perugia, Italy.

Alessandra Mirarchi (A)

Department of Medicine and Surgery, University of Perugia, 06126 Perugia, Italy.

Andrea Lazzarini (A)

Crabion S.R.L., 06100 Perugia, Italy.

Mercedes Garcia-Gil (M)

Department of Biology, Interdepartmental Research Center "Nutraceuticals and Food for Health", University of Pisa, 56127 Pisa, Italy.

Tommaso Beccari (T)

Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.

Francesco Curcio (F)

Department of Medicine, Institute of Clinical Pathology, University of Udine, 33100 Udine, Italy.

Elisabetta Albi (E)

Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH